GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Marksans Pharma Ltd (NSE:MARKSANS) » Definitions » Price-to-Tangible-Book

Marksans Pharma (NSE:MARKSANS) Price-to-Tangible-Book : (As of May. 13, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Marksans Pharma Price-to-Tangible-Book?

As of today (2024-05-13), Marksans Pharma's share price is ₹159.25. Marksans Pharma's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was ₹0.00. Hence, Marksans Pharma's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Marksans Pharma's Price-to-Tangible-Book or its related term are showing as below:

NSE:MARKSANS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.01   Med: 2.93   Max: 13.34
Current: 4.02

During the past 13 years, Marksans Pharma's highest Price to Tangible Book Ratio was 13.34. The lowest was 1.01. And the median was 2.93.

NSE:MARKSANS's Price-to-Tangible-Book is ranked worse than
71.95% of 870 companies
in the Drug Manufacturers industry
Industry Median: 2.405 vs NSE:MARKSANS: 4.02

A closely related ratio is called PB Ratio. As of today, Marksans Pharma's share price is ₹159.25. Marksans Pharma's Book Value per Sharefor the quarter that ended in Dec. 2023 was ₹0.00. Hence, Marksans Pharma's P/B Ratio of today is .


Marksans Pharma Price-to-Tangible-Book Historical Data

The historical data trend for Marksans Pharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marksans Pharma Price-to-Tangible-Book Chart

Marksans Pharma Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.17 1.01 2.49 1.67 1.92

Marksans Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.92 - 2.78 -

Competitive Comparison of Marksans Pharma's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, Marksans Pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marksans Pharma's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Marksans Pharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Marksans Pharma's Price-to-Tangible-Book falls into.



Marksans Pharma Price-to-Tangible-Book Calculation

Marksans Pharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=159.25/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Marksans Pharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Marksans Pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Marksans Pharma (NSE:MARKSANS) Business Description

Traded in Other Exchanges
Address
Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053
Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. It has a market presence with the majority of the revenue generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, India, and the Rest of the World.

Marksans Pharma (NSE:MARKSANS) Headlines

No Headlines